select trial semaglutide cardiovascular outcomes non-diabetic 2023 Beyond obesity: Novo's re-defines risk management SELECT Trial

Ask about packaging upgrades

How GLP-1 Lowers Inflammation in the Body Although originally approved for diabetes, researchers discovered something important: GLP-1 medications consistently reduce inflammation in fat tissue, the gut, the blood vessels, and even the immune system

The table below compares the dosage differences between Mounjaro and Wegovy: The starting dose for Wegovy is 0.25 mg once weekly for the first 4 weeks, and it is gradually increased every 4 weeks until you reach the maximum maintenance dose of 7.2mg/week, as shown below

Independent Wellness coordinates prescription delivery through licensed U.S

Side Effects: GLP-1 medications can sometimes cause side effects such as nausea, vomiting, diarrhea, or dizziness